Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 5 | 2025 | 877 | 0.990 |
Why?
|
| Heart | 2 | 2021 | 700 | 0.950 |
Why?
|
| Pulmonary Heart Disease | 1 | 2022 | 4 | 0.750 |
Why?
|
| Scimitar Syndrome | 1 | 2020 | 52 | 0.630 |
Why?
|
| Heart Failure | 5 | 2025 | 2393 | 0.610 |
Why?
|
| Heart, Artificial | 1 | 2019 | 69 | 0.600 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 113 | 0.590 |
Why?
|
| Pulmonary Veins | 1 | 2020 | 174 | 0.580 |
Why?
|
| Atrial Function, Left | 1 | 2018 | 31 | 0.570 |
Why?
|
| Vascular Stiffness | 1 | 2019 | 81 | 0.570 |
Why?
|
| Echocardiography, Doppler | 1 | 2018 | 172 | 0.550 |
Why?
|
| Heart Diseases | 2 | 2020 | 513 | 0.530 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 460 | 0.520 |
Why?
|
| Palliative Care | 1 | 2021 | 457 | 0.520 |
Why?
|
| Heart Atria | 1 | 2018 | 340 | 0.480 |
Why?
|
| Echocardiography | 1 | 2019 | 1129 | 0.410 |
Why?
|
| Child | 17 | 2025 | 25791 | 0.370 |
Why?
|
| Hypertension | 1 | 2019 | 1396 | 0.330 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 518 | 0.290 |
Why?
|
| Infant | 8 | 2025 | 13064 | 0.250 |
Why?
|
| Pandemics | 3 | 2023 | 1183 | 0.220 |
Why?
|
| Methylprednisolone | 1 | 2025 | 98 | 0.220 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2024 | 45 | 0.210 |
Why?
|
| Retrospective Studies | 9 | 2025 | 17424 | 0.200 |
Why?
|
| Humans | 20 | 2025 | 132132 | 0.200 |
Why?
|
| Pericarditis | 1 | 2023 | 46 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 305 | 0.190 |
Why?
|
| Pericardial Effusion | 1 | 2023 | 73 | 0.190 |
Why?
|
| Graft Rejection | 2 | 2023 | 559 | 0.190 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 178 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.180 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 129 | 0.170 |
Why?
|
| Pediatrics | 2 | 2020 | 1213 | 0.170 |
Why?
|
| Cardiologists | 1 | 2020 | 25 | 0.170 |
Why?
|
| Remote Consultation | 1 | 2020 | 25 | 0.160 |
Why?
|
| Young Adult | 4 | 2024 | 9961 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 756 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 182 | 0.160 |
Why?
|
| Biopsy | 1 | 2023 | 1284 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 560 | 0.160 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2019 | 45 | 0.150 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2019 | 73 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 199 | 0.150 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 664 | 0.150 |
Why?
|
| Adolescent | 7 | 2025 | 20564 | 0.150 |
Why?
|
| Physician's Role | 1 | 2020 | 169 | 0.150 |
Why?
|
| Ventricular Pressure | 1 | 2018 | 38 | 0.140 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 380 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 570 | 0.140 |
Why?
|
| Observer Variation | 1 | 2018 | 305 | 0.140 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 259 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2022 | 1234 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1517 | 0.130 |
Why?
|
| Child, Preschool | 6 | 2025 | 14752 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 234 | 0.130 |
Why?
|
| Heart-Assist Devices | 1 | 2025 | 1081 | 0.120 |
Why?
|
| Phenotype | 2 | 2024 | 4529 | 0.120 |
Why?
|
| Adult | 5 | 2024 | 31585 | 0.120 |
Why?
|
| Cardiology | 1 | 2020 | 498 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 380 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 391 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 551 | 0.110 |
Why?
|
| Stents | 1 | 2020 | 869 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2018 | 1452 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 495 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2025 | 1866 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2019 | 1400 | 0.100 |
Why?
|
| Pineal Gland | 1 | 2013 | 21 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2322 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1103 | 0.090 |
Why?
|
| Zebrafish | 2 | 2013 | 417 | 0.090 |
Why?
|
| Age Factors | 1 | 2018 | 2917 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 166 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 3020 | 0.090 |
Why?
|
| Male | 9 | 2025 | 64985 | 0.090 |
Why?
|
| Habenula | 1 | 2011 | 43 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 5419 | 0.080 |
Why?
|
| Prognosis | 1 | 2019 | 5014 | 0.080 |
Why?
|
| Female | 8 | 2025 | 70725 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1017 | 0.070 |
Why?
|
| Neurons | 2 | 2013 | 1998 | 0.060 |
Why?
|
| Hospitalization | 2 | 2024 | 1901 | 0.050 |
Why?
|
| Glycosylation | 1 | 2024 | 126 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1610 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2023 | 104 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 30 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 103 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 465 | 0.050 |
Why?
|
| Chest Pain | 1 | 2023 | 128 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 160 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 295 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 226 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 5169 | 0.040 |
Why?
|
| Brain | 1 | 2013 | 3183 | 0.040 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 73 | 0.040 |
Why?
|
| Medicine | 1 | 2020 | 106 | 0.040 |
Why?
|
| Graft Survival | 1 | 2021 | 474 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 672 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1057 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 372 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 489 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 483 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 504 | 0.040 |
Why?
|
| Models, Biological | 1 | 2023 | 1443 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2194 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 772 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 1581 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2019 | 1014 | 0.030 |
Why?
|
| Epithalamus | 1 | 2013 | 1 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6571 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3093 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 468 | 0.020 |
Why?
|
| Nodal Signaling Ligands | 1 | 2011 | 1 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 183 | 0.020 |
Why?
|
| SEC Translocation Channels | 1 | 2011 | 5 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 328 | 0.020 |
Why?
|
| Body Patterning | 1 | 2011 | 130 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8549 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 357 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 636 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 220 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2011 | 208 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 589 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2011 | 222 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10949 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 13034 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 6229 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 2899 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11668 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1960 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21442 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 34882 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4703 | 0.010 |
Why?
|